These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12053016)

  • 1. Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach.
    Molinaro G; Gervais N; Adam A
    Stroke; 2002 Jun; 33(6):1712-6. PubMed ID: 12053016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema.
    Blais C; Rouleau JL; Brown NJ; Lepage Y; Spence D; Munoz C; Friborg J; Geadah D; Gervais N; Adam A
    Immunopharmacology; 1999 Sep; 43(2-3):293-302. PubMed ID: 10596866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin.
    Molinaro G; Cugno M; Perez M; Lepage Y; Gervais N; Agostoni A; Adam A
    J Pharmacol Exp Ther; 2002 Oct; 303(1):232-7. PubMed ID: 12235256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fibrinolysis-induced bradykinin formation in hereditary angioedema confirmed using stored plasma and biotechnological inhibitors.
    Marceau F; Bachelard H; Rivard GÉ; Hébert J
    BMC Res Notes; 2019 May; 12(1):291. PubMed ID: 31133046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat.
    Décarie A; Raymond P; Gervais N; Couture R; Adam A
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1340-7. PubMed ID: 8897926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P.
    Blais C; Marc-Aurèle J; Simmons WH; Loute G; Thibault P; Skidgel RA; Adam A
    Peptides; 1999; 20(4):421-30. PubMed ID: 10458510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity reactions to recombinant tissue plasminogen activator.
    Alakbarzade V; O'Kane D; Pereira AC
    Pract Neurol; 2020 Feb; 20(1):75-79. PubMed ID: 31273082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation.
    Raymond P; Drapeau G; Raut R; Audet R; Marceau F; Ong H; Adam A
    J Immunol Methods; 1995 Mar; 180(2):247-57. PubMed ID: 7714339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
    Blais C; Drapeau G; Raymond P; Lamontagne D; Gervais N; Venneman I; Adam A
    Am J Physiol; 1997 Nov; 273(5):H2263-71. PubMed ID: 9374762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency.
    Charest-Morin X; Hébert J; Rivard GÉ; Bonnefoy A; Wagner E; Marceau F
    Front Immunol; 2018; 9():2183. PubMed ID: 30333824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of enalaprilat on bradykinin and des-Arg9-bradykinin release following reperfusion of the ischaemic rat heart.
    Lamontagne D; Nadeau R; Adam A
    Br J Pharmacol; 1995 Jun; 115(3):476-8. PubMed ID: 7582459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioedema from recombinant TPA administration: case report and pathophysiology review.
    Foster-Goldman A; McCarthy D
    Am J Ther; 2013; 20(6):691-3. PubMed ID: 24247033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation.
    Molinaro G; Adam A; Lepage Y; Hammerschmidt D; Koenigbauer U; Eastlund T
    Transfusion; 2002 Nov; 42(11):1458-65. PubMed ID: 12421219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator.
    Agostoni A; Gardinali M; Frangi D; Cafaro C; Conciato L; Sponzilli C; Salvioni A; Cugno M; Cicardi M
    Circulation; 1994 Dec; 90(6):2666-70. PubMed ID: 7994806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Modeling of Bradykinin-Mediated Angioedema States.
    Marceau F; Bachelard H; Charest-Morin X; Hébert J; Rivard GE
    Pharmaceuticals (Basel); 2020 Aug; 13(9):. PubMed ID: 32824891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
    Butt SK; Dawson LG; Hall JM
    Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin.
    Martins DT; Fior DR; Nakaie CR; Lindsey CJ
    Br J Pharmacol; 1991 Aug; 103(4):1851-6. PubMed ID: 1655143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants.
    Marceau F; Rivard GE; Gauthier JM; Binkley KE; Bonnefoy A; Boccon-Gibod I; Bouillet L; Picard M; Levesque G; Elfassy HL; Bachelard H; Hébert J; Bork K
    Front Med (Lausanne); 2020; 7():358. PubMed ID: 32766265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
    Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.